CD8A and cancer: Notably, although CD8+ T cells are generally considered to be mainly anti-tumour immune cells, cases with high intratumoural ribosome biogenesis-active CD8+ T cell infiltration have adverse outcomes in numerous cancers (Figs. 3k and S6g).